RETA

Reata Pharmaceuticals Stock Price

103.98
0.38 (0.37%)
Upgrade to Real-Time
Regular Market
103.98
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Reata Pharmaceuticals Inc RETA NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Previous Close Last Traded
0.38 0.37% 103.98 100.535 105.7876 104.10 103.60 14:41:21
Bid Price Ask Price Spread Spread % News
103.94 104.02 0.08 0.08% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
8,522 474,834 $ 103.26 $ 49,029,920 292,833 70.00 - 257.965
Last Trade Time Type Quantity Stock Price Currency
14:41:21 75 $ 104.02 USD

Reata Pharmaceuticals Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 3.48B 33.58M 20.94M $ 26.52M $ - -9.54 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - 0.90%

more financials information »

Reata Pharmaceuticals News

Date Time Source News Article
8/10/202006:59Edgar (US Regulatory)Quarterly Report (10-q)
8/10/202006:52Edgar (US Regulatory)Current Report Filing (8-k)
8/10/202006:45GlobeNewswire Inc.Reata Pharmaceuticals, Inc. Announces Second Quarter 2020..
8/04/202016:42Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
8/04/202016:31Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)
8/03/202006:45GlobeNewswire Inc.Reata Pharmaceuticals, Inc. to Report Second Quarter 2020..
7/30/202016:05GlobeNewswire Inc.Reata Announces the Appointment of Martin W. Edwards, M.D...
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical RETA Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week149.68157.3899.16108.321,155,130-45.70-30.53%
1 Month150.25164.7999.16122.07410,960-46.27-30.8%
3 Months152.00183.320899.16144.63411,077-48.02-31.59%
6 Months234.82234.8299.16153.52375,323-130.84-55.72%
1 Year81.08257.96570.00164.02413,85222.9028.24%
3 Years28.07257.96519.31108.61299,31375.91270.43%
5 Years11.06257.96511.0397.59245,50792.92840.14%

Reata Pharmaceuticals Description

Reata Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on identifying, developing, and commercializing therapeutics to address serious and life-threatening diseases by targeting molecular pathways. The company's product in the pipeline include bardoxolone methyl; Omaveloxolone and others.
Your Recent History
NASDAQ
RETA
Reata Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200812 18:56:22